SCHEDULE: Champlain Investment Partners Discloses 5% Stake in SI-BONE
Beneficial Ownership Report
Champlain Investment Partners, LLC has disclosed a 5.0% beneficial ownership stake in SI-BONE, Inc. common stock as of June 30, 2025.
Summary
- Champlain Investment Partners, LLC reported beneficial ownership of 2,140,074 shares of SI-BONE, Inc. common stock.
- This represents 5.0% of the total outstanding common stock of SI-BONE, Inc.
- Champlain Investment Partners, LLC holds sole voting power over 1,368,619 shares and sole dispositive power over all 2,140,074 shares.
- The ownership was reported as of June 30, 2025, with the filing submitted on August 12, 2025.
- Champlain Investment Partners, LLC is classified as an Investment Adviser (IA).
Sentiment
Score: 6
Explanation: The filing is a routine disclosure of beneficial ownership by an investment adviser. The acquisition of a 5% stake by an institutional investor can be viewed as a positive signal of confidence in the company, though the filing itself is primarily for compliance.
Positives
- A significant institutional investor, Champlain Investment Partners, LLC, has taken a 5.0% beneficial ownership stake in SI-BONE, Inc., potentially signaling confidence in the company.
Negatives
- NA
Risks
- NA
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future outlook.
Industry Context
This filing indicates an institutional investment adviser has taken a significant stake in SI-BONE, Inc., a company operating in the medical device sector. Such disclosures provide transparency on institutional interest within the industry.
Stakeholder Impact
- Shareholders: Increased transparency regarding institutional ownership. May signal increased institutional interest in SI-BONE, Inc.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement (reporting period end date for ownership). |
| 08/12/2025 | Date of filing of this Schedule 13G. |
Keywords
SI-BONE, Common Stock, Beneficial Ownership, Schedule 13G, Champlain Investment Partners, Institutional Investor, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.